NVAX 10-Q: SEC filing

Novavax

Filed with the SEC on Nov 5, 2026 · accession 0001000694-26-000022

NVAX filed a 10-Q (quarterly report) with the SEC on Nov 5, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -8.2% by the first close after the filing.

Summary of the filing

Novavax filed its Q3 2026 Form 10-Q for the period ended September 30, 2026, reporting quarterly financial results including product revenue and licensing/royalty revenue.

For details, click here →How to read a 10-Q →

Key details

FilerNovavax Inc.

How NVAX stock reacted

Close before

$10.65

Nov 4, 2026

First close after

-8.17%

$9.78

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for NVAX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for NVAX?

Click here

Frequently asked questions

What did NVAX file with the SEC on Nov 5, 2026?

NVAX filed a 10-Q (SEC filing). Novavax filed its Q3 2026 Form 10-Q for the period ended September 30, 2026, reporting quarterly financial results including product revenue and licensing/royalty revenue.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did NVAX stock react to this filing?

NVAX closed at $10.65 before the filing and $9.78 on Nov 5, 2026 (-8.17%).

Other NVAX SEC filings

Get alerts when NVAX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

NVAX overview NVAX analysis NVAX news Latest SEC filings